共 50 条
Cholesterol and obesity: A marker for Alzheimer's disease
被引:2
|作者:
Sumithra, M.
[1
]
Ancy, P. M.
[2
]
机构:
[1] SRM Inst Sci & Technol, Dept Pharmacol, Chennai 603203, Tamil Nadu, India
[2] Ezhuthachan Coll Pharmaceut Sci, Marayamuttom 695124, Kerala, India
来源:
关键词:
Cholesterol;
Alzheimer's Disease;
ApoE;
Amyloid beta;
APOLIPOPROTEIN-E;
GENE-THERAPY;
COGNITIVE FUNCTION;
OXIDATIVE STRESS;
FATTY-ACIDS;
A-BETA;
BRAIN;
METABOLISM;
TAU;
IMPAIRMENT;
D O I:
10.54085/ap.2022.11.1.27
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Modern lifestyle and fast-food consumption nature increase the cholesterol consumption and deposition in our body. It is becoming one of the key risk factors in AD development. Several genes and receptors play crucial roles in such developments. Consumption of high-fat diet and absence of physical activity can lead to obesity. Higher BMI is the indicator of obesity. Higher BMI accelerates AD development due to brain atrophy, neuroinflammation, and oxidative stress in the hippocampus. Obesity in childhood and adolescence leads to dementia and AD in later life. COVID harmfully affects Alzheimer's patients, and it is also reported that COVID related dementia and neurodegeneration is one of the prominent post-COVID complications. This review summarises the role of cholesterol in Alzheimer's disease development and the importance of genes, receptors, and diet behind this.
引用
收藏
页码:266 / 275
页数:10
相关论文